Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003702 · ClinicalTrials.gov registry record · Phase 3
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
A Phase 3 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
NCT00003702 is a Phase 3 study that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 240 participants.
The verdict
NCT00003702, a Phase 3 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
Study Summary
Randomized phase III trial to compare the effectiveness of methotrexate with that of dactinomycin in treating patients who have gestational trophoblastic neoplasia. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether methotrexate is more effective than dactinomycin in treating patients with gestational trophoblastic neoplasia.
Interventions
- DRUG Methotrexate
- BIOLOGICAL Dactinomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 1999-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003702
The ClinicalTrials.gov registry entry for NCT00003702 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methotrexate is the first listed.
NCT00003702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003702 about?
NCT00003702 is a clinical study titled "Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia". Randomized phase III trial to compare the effectiveness of methotrexate with that of dactinomycin in treating patients who have gestational trophoblastic neoplasia. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whethe...
What is the current status of trial NCT00003702?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 1999-06.
What interventions are being tested in trial NCT00003702?
The interventions under investigation include: Methotrexate (DRUG), Dactinomycin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00003702?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.